Karyopharm to present new selinexor data at the 2023 american society of clinical oncology and european hematology association annual meetings

Newton, mass. , may 23, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected to be presented at the 2023 american society of clinical oncology (asco) annual meeting, being held june 2-6 in chicago, illinois and the 2023 european hematology association (eha) hybrid congress, being held june 8-11 in frankfurt, germany.
KPTI Ratings Summary
KPTI Quant Ranking